ACE and Hypertension: Evidence has shown that hypertension can be offset by drugs that improve NO signaling or restore NO bioavailability (for example, angiotensin-converting enzyme (ACE) inhibitors promote elevated levels of bradykinin, which activates the bradykinin B2 receptor in endothelial cells and eNOS, which increases NO production) [108].